{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:11:57Z","timestamp":1770919917091,"version":"3.50.1"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.2169\/internalmedicine.3866-19","type":"journal-article","created":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T22:05:56Z","timestamp":1574028356000},"page":"705-710","source":"Crossref","is-referenced-by-count":8,"title":["Severe Mononeuritis Multiplex due to Rheumatoid Vasculitis in Rheumatoid Arthritis in Sustained Clinical Remission for Decades"],"prefix":"10.2169","volume":"59","author":[{"given":"Masanobu","family":"Tanemoto","sequence":"first","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bungo","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuna","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomihiro","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"},{"name":"Sapporo Medical University, School of Health Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Shimohama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sapporo Medical University, School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol 13: 302-316, 2017.","DOI":"10.1038\/nrneurol.2017.42"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology 53: 890-899, 2014.","DOI":"10.1093\/rheumatology\/ket475"},{"key":"3","unstructured":"3. Kimura J. Assessment of individual nerves. In: Electrodiagnosis in Diseases of Nerve and Muscle. 3rd ed. Kimura J, Ed. Oxford University Press, Oxford, 2001: 130-177."},{"key":"4","unstructured":"4. Scott DGI, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60: 288-297, 1981."},{"key":"5","unstructured":"5. Abdulqader Y, Al-ani M, Parperis K. Rheumatoid vasculitis: early presentation of rheumatoid arthritis. BMJ Case Reports. Forthcoming."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Morgan-Warren PJ, Dulku S, Ravindran J, Smith G. Peripheral ulcerative keratitis as the presenting feature of systemic rheumatoid vasculitis without joint involvement. Int Ophthalmol 34: 933-935, 2014.","DOI":"10.1007\/s10792-013-9879-3"},{"key":"7","unstructured":"7. Singh JA, Saag KG, Bridges Jr. SL, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheum 68: 1-26, 2016."},{"key":"8","unstructured":"8. Smolen JS, Landew\u00e9 R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with systemic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73: 492-509, 2014."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ntatsaki E, Mooney J, Scott DGI, Watts RA. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology 53: 145-152, 2014.","DOI":"10.1093\/rheumatology\/ket326"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Scott DGI, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76: 377-384, 1984.","DOI":"10.1016\/0002-9343(84)90654-5"},{"key":"11","unstructured":"11. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69: 1580-1588, 2010."},{"key":"12","unstructured":"12. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JMW. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 55: 190-192, 1996."},{"key":"13","first-page":"54","volume":"43","author":"DGI Scott","year":"1981","unstructured":"13. Scott DGI, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 43: 54-63, 1981.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"14","unstructured":"14. Haruta K, Kobayashi S, Tajima M, et al. Effect of immune complexes in serum from patients with rheumatoid vasculitis on the expression of cell adhesion molecules on polymorphonuclear cells. Clin Exp Rheumatol 19: 59-68, 2001."},{"key":"15","unstructured":"15. Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 46: 727-733, 1987."},{"key":"16","unstructured":"16. Lindhardsen J, Ahlehoff O, Gislason GH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 344: e1257, 2012."},{"key":"17","unstructured":"17. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis 20: 434-441, 2017."},{"key":"18","unstructured":"18. Collins MP, Dyck PJB, Gronseth GS, et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 15: 176-184, 2010."},{"key":"19","unstructured":"19. Pu\u00e9chal X, Gottenberg JE, Berthelot JM, et al. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken) 64: 331-339, 2012."},{"key":"20","unstructured":"20. Abel T, Andrews BS, Cunningham PH, Brunner CM, Davis IV JS, Horwitz DA. Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Intern Med 93: 407-413, 1980."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nicholls A, Snaith ML, Maini RN, Scott JT. Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis 32: 589-591, 1973.","DOI":"10.1136\/ard.32.6.589"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Heurkens AHM, Westedt ML, Breedveld FC. Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis. Arch Intern Med 151: 2249-2254, 1991.","DOI":"10.1001\/archinte.151.11.2249"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36-44, 2003.","DOI":"10.1056\/NEJMoa020286"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3866-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T03:21:20Z","timestamp":1583551280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3866-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3866-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}